These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15195932)

  • 1. Novel approaches to ocular drug delivery.
    Davis JL; Gilger BC; Robinson MR
    Curr Opin Mol Ther; 2004 Apr; 6(2):195-205. PubMed ID: 15195932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in drug delivery systems for treating ocular complications of systemic diseases.
    Lee SS; Hughes PM; Robinson MR
    Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industrial perspective in ocular drug delivery.
    Ali Y; Lehmussaari K
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy in ocular diseases.
    Singh VK; Tripathi P
    Indian J Ophthalmol; 2002 Sep; 50(3):173-81. PubMed ID: 12355690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
    Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein delivery for retinal diseases: from basic considerations to clinical applications.
    El Sanharawi M; Kowalczuk L; Touchard E; Omri S; de Kozak Y; Behar-Cohen F
    Prog Retin Eye Res; 2010 Nov; 29(6):443-65. PubMed ID: 20398784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in ocular drug delivery.
    Weiner AL; Gilger BC
    Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular gene therapy: a review of nonviral strategies.
    Andrieu-Soler C; Bejjani RA; de Bizemont T; Normand N; BenEzra D; Behar-Cohen F
    Mol Vis; 2006 Oct; 12():1334-47. PubMed ID: 17110916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene delivery to the retina: focus on non-viral approaches.
    Naik R; Mukhopadhyay A; Ganguli M
    Drug Discov Today; 2009 Mar; 14(5-6):306-15. PubMed ID: 18973824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
    Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices for the treatment of eye diseases.
    Yasukawa T; Ogura Y
    Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.